该协会的Redox调节药物目标基因与精神疾病:一个门德尔的随机化研究研究
相关实验视频
Updated: Jun 27, 2025

Developing a Rat Model for Bipolar Disorder
Published on: May 2, 2025
Zhe Lu1,2,3, Yang Yang4, Guorui Zhao1,2,3
1Institute of Mental Health, Peking University Sixth Hospital, No. 51 Hua Yuan Bei Road, Beijing 100191, China.
毒监管药物目标显示了与精神病风险的潜在联系. 维生素C,E和黑激素标的遗传变异与精神分裂症,双相情感障碍和严重抑郁症有关,部分是由认知介导的.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 遗传学 是一个
- 药理学 药理学是指药理学的学科.
背景情况:
- 大脑对氧化应激失衡的易感性表明,氧化调节药物 (RRD) 标是精神病的潜在新型治疗标.
- 了解RRD目标与精神病风险之间的遗传联系对于开发新疗法至关重要.
研究的目的:
- 调查RRD目标的扰乱与发展各种精神障碍的风险之间的潜在关联.
- 探索认知功能在这些关联中的调解作用.
主要方法:
- 使用门德尔的随机化分析来评估因果关系.
- 用表达量性特征位点 (eQTL) 和蛋白质量性特征位点 (pQTL) 数据来导出遗传仪器变量.
- 分析了七种精神病的全基因组关联研究总结数据,包括精神分裂症 (SCZ),双相情感障碍 (BD) 和主要抑郁障碍 (MDD).
主要成果:
- 维生素C标 (OGFOD2,P4HTM) 和黑素标 (RORB) 的遗传变异与SCZ的风险有显著的关联.
- 维生素E标 (PRKCB) 的遗传变异与BD风险增加有关.
- 维生素C标 (P4HTM) 的遗传变异与MDD风险增加有关,其影响由认知功能介导.
结论:
- 这项研究提供了证据,支持RRD目标与SCZ,BD和MDD风险之间的因果关系.
- 认知功能部分调解了RRD目标和精神病风险之间的因果关系.
- 研究和开发的目标代表了未来精神病的研究和治疗发展的有希望的途径.
更多相关视频
07:38Functional Characterization of Na+/H+ Exchangers of Intracellular Compartments Using Proton-killing Selection to Express Them at the Plasma Membrane
Published on: March 30, 2015
08:15Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
Published on: June 6, 2025
相关概念视频
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Biological Causes of Schizophrenia
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
Antidepressant Drugs: MAOIs and Other Agents
Genetic Lingo